FDA tags Medtronic embolisation device recall
Medtronic's standing as the largest pure ... We estimate 4% average annual revenue growth from the cardiovascular group through fiscal 2029, and 5% annualized growth in the neuroscience unit ...
Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...
Medtronic plc (NYSE:MDT – Get Free Report) has received a consensus rating of “Hold” from the sixteen ratings firms that are ...
Miniaturized pacemakers were successfully implanted in infants and neonates requiring pacing and performed reliably until ...
The Medtronic Prevail drug coated balloon [Image courtesy of ... Dr. Sacharias von Koch of the Deptartment of Cardiology ...
Shares of Medtronic plc (NYSE:MDT – Get Free Report) shot up 0.1% during mid-day trading on Friday following a dividend announcement from the company. The company traded as high as $93.27 and last ...
Product-wise, Medtronic's cardiovascular, neuroscience, and surgical segments comprise most of the business, with a minor contribution from its diabetes unit. That diversity helps ensure stability ...
Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international ...
Also Read: Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast This feature personalizes therapy based on a patient’s brain acti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results